Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Irinotecan Hydrochloride Injection

Approval Number

国药准字H20213205

Company四川汇宇制药股份有限公司

Registration Date

March 23, 2021

Drug Information

Generic Name

盐酸伊立替康注射液

Dosage Form

注射剂

Strength

按C33H38N4O6·HCl·3H2O计 2ml:40mg

Drug Type

化学药品

Registration Date

March 23, 2021

Company Information

Applicant Company

Company Name四川汇宇制药股份有限公司

Company Address

四川省内江市市中区汉阳路333号3幢

Manufacturing Company

Company Name四川汇宇制药股份有限公司

Company Address

四川省内江市市中区汉阳路333号3幢

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy